Discover the incredible journey of Gene Lay, the founder of BioLegend, who turned an initial investment of $262,500 into nearly 300 times its value in just a decade!
 
Gene Lay shared his entrepreneurial success story at the "2024 Biotech Trends and Opportunities: From Lab Innovation to Industry Application" forum at NHRI on the 15th. The National Health Research Institutes even appointed him as an unpaid research consultant during the event.
 
Dive into the details:
https://news.gbimonthly.com/tw/article/show.php?num=64320
 
Learn more about BioLegend's phenomenal rise from a $262,500 startup to acquisition by PerkinElmer in just ten years! Read our exclusive coverage from our on-site visit in San Diego in 2019.
 
https://reurl.cc/or7erV
 
Follow #Globalbio for more insightful updates!
#BioLegend #BiotechSuccess #InnovationJourney #BiotechTrends